Clonazepam
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Synonyms / Brand Names: Antelepsin, Antilepsin , Cloazepam, Clonopin, Iktorivil , Klonopin, Klonopin rapidly disintegrating, Landsen, Rivotril
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Dosing and Administration
Seizure disorder: For adults, the initial dose for adults with seizure disorders should not exceed 1.5 mg/day divided into three doses. Maintenance dosage must be individualized for each patient depending upon response. Maximum recommended daily dose is 20 mg. For pediatric patients: the initial dose for infants and children (up to 10 years of age or 30 kg of body weight) should be between 0.01 and 0.03 mg/kg/day but not to exceed 0.05 mg/kg/day given in two or three divided doses. Dosage should be increased by no more than 0.25 to 0.5 mg every third day until a daily maintenance dose of 0.1 to 0.2 mg/kg of body weight has been reached, unless seizures are controlled or side effects preclude further increase.
Panic disorder:For adults, he initial dose for adults with panic disorder is 0.25 mg bid. An increase to the target dose for most patients of 1 mg/day may be made after 3 days. The maximum dose is 4 mg/day. For pediatric patients, there is no clinical trial experience.
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Clonazepam
Return to top
Publication Resources
Most Recent Articles on Clonazepam
Review Articles on Clonazepam
Articles on Clonazepam in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Clonazepam
Return to top
Trial Resources
Ongoing Trials with Clonazepam at Clinical Trials.gov
Trial Results with Clonazepam
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Clonazepam
Cochrane Collaboration on Clonazepam
Cost Effectiveness of Clonazepam
Return to top
Media Resources
Powerpoint Slides on Clonazepam
Images of Clonazepam
Podcasts & MP3s on Clonazepam
Videos on Clonazepam
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Clonazepam
Discussion Groups on Clonazepam
Patient Handouts on Clonazepam
Blogs on Clonazepam
Clonazepam in the News
Clonazepam in the Marketplace
Return to top
International Resources
Clonazepam en Español
Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
